Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Proteome Based Approach Defines Candidates for Designing a Multitope Vaccine against the Nipah Virus
Mohamed A. Soltan, Muhammad Alaa Eldeen, Nada Elbassiouny, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9330-9330
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Design, synthesis, and SAR studies of novel 4-methoxyphenyl pyrazole and pyrimidine derivatives as potential dual tyrosine kinase inhibitors targeting both EGFR and VEGFR-2
Abeer M. El‐Naggar, A.M.A. Hassan, Eslam B. Elkaeed, et al.
Bioorganic Chemistry (2022) Vol. 123, pp. 105770-105770
Closed Access | Times Cited: 77
Nipah Virus–Another Threat From the World of Zoonotic Viruses
Krzysztof Skowron, Justyna Bauza-Kaszewska, Katarzyna Grudlewska‐Buda, et al.
Frontiers in Microbiology (2022) Vol. 12
Open Access | Times Cited: 71
Pimenta dioica (L.) Merr. Bioactive Constituents Exert Anti-SARS-CoV-2 and Anti-Inflammatory Activities: Molecular Docking and Dynamics, In Vitro, and In Vivo Studies
Heba A. El Gizawy, Sylvia A. Boshra, Ahmed Mostafa, et al.
Molecules (2021) Vol. 26, Iss. 19, pp. 5844-5844
Open Access | Times Cited: 75
Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2
Ahmed A. Al‐Karmalawy, Mai M. Farid, Ahmed Mostafa, et al.
Molecules (2021) Vol. 26, Iss. 21, pp. 6559-6559
Open Access | Times Cited: 71
Investigating the structure–activity relationship of marine natural polyketides as promising SARS-CoV-2 main protease inhibitors
Amr El‐Demerdash, Ahmed A. Al‐Karmalawy, Tarek Mohamed Abd El‐Aziz, et al.
RSC Advances (2021) Vol. 11, Iss. 50, pp. 31339-31363
Open Access | Times Cited: 70
In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity
Ayman Abo Elmaaty, Khaled M. Darwish, Amani Chrouda, et al.
ACS Omega (2021) Vol. 7, Iss. 1, pp. 875-899
Open Access | Times Cited: 69
In vitro and computational insights revealing the potential inhibitory effect of Tanshinone IIA against influenza A virus
Dalia Elebeedy, Ingy Badawy, Ayman Abo Elmaaty, et al.
Computers in Biology and Medicine (2021) Vol. 141, pp. 105149-105149
Closed Access | Times Cited: 57
Newly synthesized series of oxoindole–oxadiazole conjugates as potential anti-SARS-CoV-2 agents:in silicoandin vitrostudies
Rana M. El-Masry, Ahmed A. Al‐Karmalawy, Radwan Alnajjar, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 11, pp. 5078-5090
Closed Access | Times Cited: 55
Synthesis, structural characterization, DFT calculations, molecular docking, and molecular dynamics simulations of a novel ferrocene derivative to unravel its potential antitumor activity
Mohamed M. Hammoud, Muhammad Khattab, Marwa Abdel‐Motaal, et al.
Journal of Biomolecular Structure and Dynamics (2022), pp. 1-18
Open Access | Times Cited: 52
Anticoagulants as Potential SARS-CoV-2 Mpro Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR Studies
Ayman Abo Elmaaty, Wagdy M. Eldehna, Muhammad Khattab, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12235-12235
Open Access | Times Cited: 42
Design and synthesis of novel benzoazoninone derivatives as potential CBSIs and apoptotic inducers: In Vitro, in Vivo, molecular docking, molecular dynamics, and SAR studies
Mohamed M. Hammouda, Ayman Abo Elmaaty, Mohamed S. Nafie, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105995-105995
Closed Access | Times Cited: 41
Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah Vaccine
Rebecca J. Loomis, Anthony DiPiazza, Samantha Falcone, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 42
Design, synthesis, biological evaluation, and SAR studies of novel cyclopentaquinoline derivatives as DNA intercalators, topoisomerase II inhibitors, and apoptotic inducers
Mohamed M. Hammoud, Alaa S. Nageeb, M.A. Morsi, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 23, pp. 11422-11436
Closed Access | Times Cited: 35
Ligand-based design, synthesis, computational insights, andin vitrostudies of novelN-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease
Mohamed Elagawany, Ayman Abo Elmaaty, Ahmed Mostafa, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2112-2132
Open Access | Times Cited: 35
Synthesis, Molecular Docking Study, and Cytotoxicity Evaluation of Some Novel 1,3,4-Thiadiazole as Well as 1,3-Thiazole Derivatives Bearing a Pyridine Moiety
Amr S. Abouzied, Jehan Y. Al‐Humaidi, Abdulrahman S. Bazaid, et al.
Molecules (2022) Vol. 27, Iss. 19, pp. 6368-6368
Open Access | Times Cited: 34
Biological evaluation, docking studies, and in silico ADME prediction of some pyrimidine and pyridine derivatives as potential EGFR WT and EGFR T790M inhibitors
Tarfah Al‐Warhi, Ahmed A. Al‐Karmalawy, Ayman Abo Elmaaty, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 38, Iss. 1, pp. 176-191
Open Access | Times Cited: 29
Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview
Ahmed A. Al‐Karmalawy, Raya Soltane, Ayman Abo Elmaaty, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1317-1317
Open Access | Times Cited: 39
Rumex Vesicarius L. extract improves the efficacy of doxorubicin in triple-negative breast cancer through inhibiting Bcl2, mTOR, JNK1 and augmenting p21 expression
Aml Ghanem, Ahmed A. Al‐Karmalawy, Ahmed I. Abd El Maksoud, et al.
Informatics in Medicine Unlocked (2022) Vol. 29, pp. 100869-100869
Open Access | Times Cited: 26
Smart therapies against global pandemics: A potential of short peptides
Vasso Apostolopoulos, Joanna Bojarska, Jack Feehan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 21
Regulation of Host Immune Response against Enterobacter cloacae Proteins via Computational mRNA Vaccine Design through Transcriptional Modification
Muhammad Naveed, Khizra Jabeen, Rubina Naz, et al.
Microorganisms (2022) Vol. 10, Iss. 8, pp. 1621-1621
Open Access | Times Cited: 21
Exploring the structural basis to develop efficient multi-epitope vaccines displaying interaction with HLA and TAP and TLR3 molecules to prevent NIPAH infection, a global threat to human health
Sukrit Srivastava, Sonia Verma, Mohit Kamthania, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0282580-e0282580
Open Access | Times Cited: 13
In silico Designing of an Epitope-Based Vaccine Against Common E. coli Pathotypes
Mohamed A. Soltan, Mohammed Y. Behairy, Mennatallah S. Abdelkader, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 16
Exploring the influence of burial and cremation practices on Nipah virus transmission: a SIRD model analysis
Khadija Tul Kubra, Samra Gulshan, Rooh Ali
Modeling Earth Systems and Environment (2024) Vol. 10, Iss. 4, pp. 4759-4786
Closed Access | Times Cited: 3
Mining of Marburg Virus Proteome for Designing an Epitope-Based Vaccine
Mohamed A. Soltan, Waleed K. Abdulsahib, Mahmoud Amer, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Challenges and considerations in multi-epitope vaccine design surrounding toll-like receptors
Masaud Shah, Sobia Rafiq, Hyun Goo Woo
Trends in Pharmacological Sciences (2024)
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top